Wood, P., Desai, J., Waldeck, K., Cain, J., Gottardo, N., Strong, R., … Ashley, D. (2020). A PHASE II STUDY OF CONTINUOUS LOW DOSE PANOBINOSTAT IN PAEDIATRIC PATIENTS WITH MALIGNANT RHABDOID TUMORS/ATYPICAL TERATOID RHABDOID TUMORS. In NEURO-ONCOLOGY (Vol. 22, pp. 277–277).

Wood, Paul, Jayesh Desai, Kelly Waldeck, Jason Cain, Nick Gottardo, Robyn Strong, Kathryn Kinross, et al. “A PHASE II STUDY OF CONTINUOUS LOW DOSE PANOBINOSTAT IN PAEDIATRIC PATIENTS WITH MALIGNANT RHABDOID TUMORS/ATYPICAL TERATOID RHABDOID TUMORS.” In NEURO-ONCOLOGY, 22:277–277, 2020.

Wood P, Desai J, Waldeck K, Cain J, Gottardo N, Strong R, et al. A PHASE II STUDY OF CONTINUOUS LOW DOSE PANOBINOSTAT IN PAEDIATRIC PATIENTS WITH MALIGNANT RHABDOID TUMORS/ATYPICAL TERATOID RHABDOID TUMORS. In: NEURO-ONCOLOGY. 2020. p. 277–277.

Wood, Paul, et al. “A PHASE II STUDY OF CONTINUOUS LOW DOSE PANOBINOSTAT IN PAEDIATRIC PATIENTS WITH MALIGNANT RHABDOID TUMORS/ATYPICAL TERATOID RHABDOID TUMORS.” NEURO-ONCOLOGY, vol. 22, 2020, pp. 277–277.

Wood P, Desai J, Waldeck K, Cain J, Gottardo N, Strong R, Kinross K, Carr M, Jones J, Wong L, Ziegler D, Hansford J, Michael M, Ashley D. A PHASE II STUDY OF CONTINUOUS LOW DOSE PANOBINOSTAT IN PAEDIATRIC PATIENTS WITH MALIGNANT RHABDOID TUMORS/ATYPICAL TERATOID RHABDOID TUMORS. NEURO-ONCOLOGY. 2020. p. 277–277.